Search

Sarae L. Bausch

Examiner (ID: 9546, Phone: (571)272-2912 , Office: P/1634 )

Most Active Art Unit
1634
Art Unit(s)
1634, 1699
Total Applications
1025
Issued Applications
192
Pending Applications
210
Abandoned Applications
650

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18077832 [patent_doc_number] => 20220403444 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-22 [patent_title] => PROXIMITY-DRIVEN ACTIVATION OF CRISPR-CAS SYSTEMS FOR DETECTION OF DIVERSE MOLECULAR ANALYTES [patent_app_type] => utility [patent_app_number] => 17/606225 [patent_app_country] => US [patent_app_date] => 2020-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15695 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17606225 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/606225
PROXIMITY-DRIVEN ACTIVATION OF CRISPR-CAS SYSTEMS FOR DETECTION OF DIVERSE MOLECULAR ANALYTES Apr 26, 2020 Pending
Array ( [id] => 17897347 [patent_doc_number] => 20220307009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => ISOLATED NUCLEIC ACID BINDING DOMAINS [patent_app_type] => utility [patent_app_number] => 17/594277 [patent_app_country] => US [patent_app_date] => 2020-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25266 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594277 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/594277
ISOLATED NUCLEIC ACID BINDING DOMAINS Apr 26, 2020 Pending
Array ( [id] => 17642370 [patent_doc_number] => 20220170108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-02 [patent_title] => METHOD FOR DIAGNOSING CANCER USING CFDNA [patent_app_type] => utility [patent_app_number] => 17/594063 [patent_app_country] => US [patent_app_date] => 2020-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55430 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594063 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/594063
METHOD FOR DIAGNOSING CANCER USING CFDNA Apr 2, 2020 Pending
Array ( [id] => 17657512 [patent_doc_number] => 20220177977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => APPARATUS, SYSTEM AND METHOD [patent_app_type] => utility [patent_app_number] => 17/598324 [patent_app_country] => US [patent_app_date] => 2020-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6488 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17598324 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/598324
APPARATUS, SYSTEM AND METHOD Mar 25, 2020 Pending
Array ( [id] => 18198054 [patent_doc_number] => 20230051573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-16 [patent_title] => METHODS AND KITS FOR DETECTING RHOA MUTATIONS [patent_app_type] => utility [patent_app_number] => 17/441047 [patent_app_country] => US [patent_app_date] => 2020-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25453 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17441047 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/441047
METHODS AND KITS FOR DETECTING RHOA MUTATIONS Mar 18, 2020 Abandoned
Array ( [id] => 20386817 [patent_doc_number] => 12486536 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-12-02 [patent_title] => MicroRNA regulatory network as biomarkers of seizure in patients with spontaneous intracerebral hemorrhage [patent_app_type] => utility [patent_app_number] => 17/438288 [patent_app_country] => US [patent_app_date] => 2020-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16700 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17438288 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/438288
MicroRNA regulatory network as biomarkers of seizure in patients with spontaneous intracerebral hemorrhage Mar 9, 2020 Issued
Array ( [id] => 17564394 [patent_doc_number] => 20220128543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => MACROPHAGE MARKERS IN CANCER [patent_app_type] => utility [patent_app_number] => 17/436163 [patent_app_country] => US [patent_app_date] => 2020-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32116 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17436163 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/436163
MACROPHAGE MARKERS IN CANCER Mar 5, 2020 Abandoned
Array ( [id] => 18021076 [patent_doc_number] => 20220372575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => A KIT FOR DETECTION OF MUTATIONS CAUSING GENETIC DISORDERS [patent_app_type] => utility [patent_app_number] => 17/763340 [patent_app_country] => US [patent_app_date] => 2020-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5560 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17763340 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/763340
A KIT FOR DETECTION OF MUTATIONS CAUSING GENETIC DISORDERS Mar 1, 2020 Pending
Array ( [id] => 17595822 [patent_doc_number] => 20220145396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => METHOD OF IDENTIFYING PATIENTS WITH BORTEZOMIB RESISTANT MULTIPLE MYELOMA AND OTHER BLOOD DISEASES [patent_app_type] => utility [patent_app_number] => 17/436117 [patent_app_country] => US [patent_app_date] => 2020-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22636 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17436117 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/436117
METHOD OF IDENTIFYING PATIENTS WITH BORTEZOMIB RESISTANT MULTIPLE MYELOMA AND OTHER BLOOD DISEASES Feb 27, 2020 Abandoned
Array ( [id] => 17563532 [patent_doc_number] => 20220127681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => SORTING CELL-TYPE SPECIFIC EXTRACELLULAR VESICLES [patent_app_type] => utility [patent_app_number] => 17/434558 [patent_app_country] => US [patent_app_date] => 2020-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9580 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -40 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17434558 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/434558
SORTING CELL-TYPE SPECIFIC EXTRACELLULAR VESICLES Feb 26, 2020 Abandoned
Array ( [id] => 17482705 [patent_doc_number] => 20220090209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => RETROTRANSPOSON BIOMARKERS [patent_app_type] => utility [patent_app_number] => 17/430873 [patent_app_country] => US [patent_app_date] => 2020-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45127 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430873 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/430873
RETROTRANSPOSON BIOMARKERS Feb 12, 2020 Abandoned
Array ( [id] => 16238674 [patent_doc_number] => 20200255908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-13 [patent_title] => GENES AND GENE SIGNATURES FOR DIAGNOSIS AND TREATMENT OF MELANOMA [patent_app_type] => utility [patent_app_number] => 16/786780 [patent_app_country] => US [patent_app_date] => 2020-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40079 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16786780 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/786780
Genes and gene signatures for diagnosis and treatment of melanoma Feb 9, 2020 Issued
Array ( [id] => 17564416 [patent_doc_number] => 20220128565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => ANALYTE DETECTION BY SELECTIVE LABELING OF BIOLOGICAL SAMPLES [patent_app_type] => utility [patent_app_number] => 17/428410 [patent_app_country] => US [patent_app_date] => 2020-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17888 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428410 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/428410
ANALYTE DETECTION BY SELECTIVE LABELING OF BIOLOGICAL SAMPLES Feb 3, 2020 Pending
Array ( [id] => 17595821 [patent_doc_number] => 20220145395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => Transpochimeric Gene Transcripts (TCGTS) As Cancer Biomarkers [patent_app_type] => utility [patent_app_number] => 17/419990 [patent_app_country] => US [patent_app_date] => 2020-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17754 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17419990 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/419990
Transpochimeric Gene Transcripts (TCGTS) As Cancer Biomarkers Jan 2, 2020 Pending
Array ( [id] => 17750020 [patent_doc_number] => 20220228225 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => SNP MARKER COMBINATION AND IDENTIFICATION METHOD FOR PUDONG WHITE PIGS AND RAW MEAT PRODUCTS [patent_app_type] => utility [patent_app_number] => 17/042122 [patent_app_country] => US [patent_app_date] => 2019-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2175 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17042122 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/042122
SNP MARKER COMBINATION AND IDENTIFICATION METHOD FOR PUDONG WHITE PIGS AND RAW MEAT PRODUCTS Dec 30, 2019 Abandoned
Array ( [id] => 16091395 [patent_doc_number] => 20200199684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-25 [patent_title] => METHOD FOR PROGNOSIS OF RENAL CELL CARCINOMA [patent_app_type] => utility [patent_app_number] => 16/708879 [patent_app_country] => US [patent_app_date] => 2019-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17152 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16708879 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/708879
METHOD FOR PROGNOSIS OF RENAL CELL CARCINOMA Dec 9, 2019 Abandoned
Array ( [id] => 17370414 [patent_doc_number] => 20220025466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => DIFFERENTIAL METHYLATION [patent_app_type] => utility [patent_app_number] => 17/309348 [patent_app_country] => US [patent_app_date] => 2019-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49201 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309348 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/309348
DIFFERENTIAL METHYLATION Nov 28, 2019 Pending
Array ( [id] => 17357171 [patent_doc_number] => 20220017967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => MOLECULAR SIGNATURE [patent_app_type] => utility [patent_app_number] => 17/309349 [patent_app_country] => US [patent_app_date] => 2019-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32740 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309349 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/309349
MOLECULAR SIGNATURE Nov 28, 2019 Pending
Array ( [id] => 17642372 [patent_doc_number] => 20220170110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-02 [patent_title] => CANCER DIAGNOSTIC MARKER USING TRANSPOSASE-ACCESSIBLE CHROMATIN SEQUENCING INFORMATION ABOUT INDIVIDUAL, AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/601332 [patent_app_country] => US [patent_app_date] => 2019-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7936 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17601332 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/601332
CANCER DIAGNOSTIC MARKER USING TRANSPOSASE-ACCESSIBLE CHROMATIN SEQUENCING INFORMATION ABOUT INDIVIDUAL, AND USE THEREOF Nov 18, 2019 Abandoned
Array ( [id] => 18264494 [patent_doc_number] => 20230085736 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => PRIMER FOR DETECTING FECAL POLLUTION IN WATER, KIT AND HIGH-THROUGHPUT TRACING METHOD [patent_app_type] => utility [patent_app_number] => 16/958737 [patent_app_country] => US [patent_app_date] => 2019-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3367 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16958737 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/958737
PRIMER FOR DETECTING FECAL POLLUTION IN WATER, KIT AND HIGH-THROUGHPUT TRACING METHOD Nov 14, 2019 Abandoned
Menu